{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Depression", "Hypericum perforatum", "Neurotransmitters", "St. John\u02bcs wort"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35294606", "DateCompleted": {"Year": "2022", "Month": "05", "Day": "09"}, "DateRevised": {"Year": "2023", "Month": "09", "Day": "25"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "03", "Day": "16"}], "Language": ["eng"], "ELocationID": ["10.1007/s00210-022-02229-z"], "Journal": {"ISSN": "1432-1912", "JournalIssue": {"Volume": "395", "Issue": "6", "PubDate": {"Year": "2022", "Month": "Jun"}}, "Title": "Naunyn-Schmiedeberg's archives of pharmacology", "ISOAbbreviation": "Naunyn Schmiedebergs Arch Pharmacol"}, "ArticleTitle": "St. John's wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems?", "Pagination": {"StartPage": "629", "EndPage": "642", "MedlinePgn": "629-642"}, "Abstract": {"AbstractText": ["St. John's wort (Hypericum perforatum) is a herbaceous plant containing many bioactive molecules including naphthodianthrones, phloroglucinol derivatives, flavonoids, bioflavonoids, proanthocyanidins, and chlorogenic acid. Evidence has shown the therapeutic effects of St. John's wort and especially its two major active components, hyperforin and hypericin, on different psychiatric and mood disorders such as posttraumatic stress disorder (PTSD), attention-deficit hyperactivity disorder (ADHD), obsessive-compulsive disorder (OCD), and anxiety disorders. St. John's wort also induces antidepressant effects. In this review study, we aimed to discuss the role of St. John's wort in modulating depression, with respect to the role of different neurotransmitter systems in the brain. We discussed changes in the neurotransmitter levels in depression, and following use of St. John's wort. It was concluded that changes in the function and level of neurotransmitters in depression are complex. Also, St. John's wort can induce inconsistent effects on neurotransmitter levels. We also found that glutamate and acetylcholine may be the most important neurotransmitters to study in future works, because the function of both neurotransmitters in depression is unclear. In addition, St. John's wort induces a dualistic modulation on the activity of cholinergic signaling, which can be an interesting topic for future studies."], "CopyrightInformation": "\u00a9 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Psychology, Faculty of Human Sciences, Tonekabon Branch, Islamic Azad University, Tonekabon, Iran."}], "LastName": "Kholghi", "ForeName": "Gita", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute for Cognitive and Brain Sciences, Shahid Beheshti University, Tehran, Iran."}], "LastName": "Arjmandi-Rad", "ForeName": "Shirin", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Zarrindast", "ForeName": "Mohammad-Reza", "Initials": "MR"}, {"Identifier": ["0000-0002-2436-9887"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, P.O. Box: 1419815477, Karaj, Iran. vaseghi@imp.ac.ir."}], "LastName": "Vaseghi", "ForeName": "Salar", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Naunyn Schmiedebergs Arch Pharmacol", "NlmUniqueID": "0326264", "ISSNLinking": "0028-1298"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Neurotransmitter Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Oils"}], "MeshHeadingList": [{"QualifierName": ["drug therapy"], "DescriptorName": "Depression"}, {"QualifierName": [], "DescriptorName": "Hypericum"}, {"QualifierName": [], "DescriptorName": "Neurotransmitter Agents"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plant Oils"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "aan het Rot M, Collins KA, Murrough JW, Perez AM, Reich DL, Charney DS, Mathew SJ, (2010) Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression. Biol Psychiatry 67:139\u2013145", "ArticleIdList": ["10.1016/j.biopsych.2009.08.038"]}, {"Citation": "Abdallah CG, Sanacora G, Duman RS, Krystal JH (2018) The neurobiology of depression, ketamine and rapid-acting antidepressants: is it glutamate inhibition or activation? Pharmacol Ther 190:148\u2013158", "ArticleIdList": ["29803629", "6165688", "10.1016/j.pharmthera.2018.05.010"]}, {"Citation": "Afzal A, Batool Z, Sadir S, Liaquat L, Shahzad S, Tabassum S, Ahmad S, Kamil N, Perveen T, Haider S (2021) Therapeutic potential of curcumin in reversing the depression and associated pseudodementia via modulating stress hormone, hippocampal neurotransmitters, and BDNF levels in rats. Neurochem Res 46:3273\u20133285", "ArticleIdList": ["34409523", "10.1007/s11064-021-03430-x"]}, {"Citation": "Ago Y, Tanabe W, Higuchi M, Tsukada S, Tanaka T, Yamaguchi T, Igarashi H, Yokoyama R, Seiriki K, Kasai A, Nakazawa T, Nakagawa S, Hashimoto K, Hashimoto H (2019) (R)-Ketamine induces a greater increase in prefrontal 5-HT release than (S)-ketamine and ketamine metabolites via an AMPA receptor-independent mechanism. Int J Neuropsychopharmacol 22:665\u2013674", "ArticleIdList": ["31325908", "6822138", "10.1093/ijnp/pyz041"]}, {"Citation": "Anacker C, Hen R (2017) Adult hippocampal neurogenesis and cognitive flexibility\u2014linking memory and mood. Nat Rev Neurosci 18:335\u2013346", "ArticleIdList": ["28469276", "6261347", "10.1038/nrn.2017.45"]}, {"Citation": "Andren L, Andreasson A, Eggertsen R (2007) Interaction between a commercially available St. John\u2019s wort product (Movina) and atorvastatin in patients with hypercholesterolemia. Eur J Clin Pharmacol 63:913\u2013916", "ArticleIdList": ["17701167", "10.1007/s00228-007-0345-x"]}, {"Citation": "Arias HR, Targowska-Duda KM, Garcia-Colunga J, Ortells MO (2021) Is the antidepressant activity of selective serotonin reuptake inhibitors mediated by nicotinic acetylcholine receptors? Molecules 26"}, {"Citation": "Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng PF, Kavalali ET, Monteggia LM (2011) NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475:91\u201395", "ArticleIdList": ["21677641", "3172695", "10.1038/nature10130"]}, {"Citation": "Behnke K, Jensen GS, Graubaum HJ, Gruenwald J (2002) Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depression. Adv Ther 19:43\u201352", "ArticleIdList": ["12008860", "10.1007/BF02850017"]}, {"Citation": "Belujon P, Grace AA (2017) Dopamine system dysregulation in major depressive disorders. Int J Neuropsychopharmacol 20:1036\u20131046", "ArticleIdList": ["29106542", "5716179", "10.1093/ijnp/pyx056"]}, {"Citation": "Blier P, El Mansari M (2013) Serotonin and beyond: therapeutics for major depression. Philos Trans R Soc Lond B Biol Sci 368:20120536", "ArticleIdList": ["23440470", "3638389", "10.1098/rstb.2012.0536"]}, {"Citation": "Bonaterra GA, Schwendler A, Huther J, Schwarzbach H, Schwarz A, Kolb C, Abdel-Aziz H, Kinscherf R (2017) Neurotrophic, cytoprotective, and anti-inflammatory effects of St. John's wort extract on differentiated mouse hippocampal HT-22 neurons. Front Pharmacol 8: 955"}, {"Citation": "Bonaterra GA, Mierau O, Hofmann J, Schwarzbach H, Aziz-Kalbhenn H, Kolb C, Kinscherf R (2020) In vitro effects of St. John's wort extract against inflammatory and oxidative stress and in the phagocytic and migratory activity of mouse SIM-A9 microglia. Front Pharmacol 11: 603575"}, {"Citation": "Bowers MB Jr, Goodman E, Sim VM (1964) Some behavioral changes in man following anticholinesterase administration. J Nerv Ment Dis 138:383\u2013389", "ArticleIdList": ["14141895", "10.1097/00005053-196404000-00009"]}, {"Citation": "Bradley AJ, Lenox-Smith AJ (2013) Does adding noradrenaline reuptake inhibition to selective serotonin reuptake inhibition improve efficacy in patients with depression? A systematic review of meta-analyses and large randomised pragmatic trials. J Psychopharmacol 27:740\u2013758", "ArticleIdList": ["23832963", "10.1177/0269881113494937"]}, {"Citation": "Brattstrom A (2009) Long-term effects of St. John\u2019s wort (Hypericum perforatum) treatment: a 1-year safety study in mild to moderate depression. Phytomedicine 16:277\u2013283", "ArticleIdList": ["19299116", "10.1016/j.phymed.2008.12.023"]}, {"Citation": "Breyer A, Elstner M, Gillessen T, Weiser D, Elstner E (2007) Glutamate-induced cell death in neuronal HT22 cells is attenuated by extracts from St. John\u2019s wort (Hypericum perforatum L.). Phytomedicine 14:250\u2013255", "ArticleIdList": ["17346956", "10.1016/j.phymed.2007.02.001"]}, {"Citation": "Buchholzer ML, Dvorak C, Chatterjee SS, Klein J (2002) Dual modulation of striatal acetylcholine release by hyperforin, a constituent of St. John\u2019s Wort J Pharmacol Exp Ther 301:714\u2013719", "ArticleIdList": ["11961077", "10.1124/jpet.301.2.714"]}, {"Citation": "Bukhari IA, Dar A (2013) Behavioral profile of Hypericum perforatum (St. John\u2019s wort) extract. A comparison with standard antidepressants in animal models of depression. Eur Rev Med Pharmacol Sci 17:1082\u20131089", "ArticleIdList": ["23661522"]}, {"Citation": "Butterweck V, Bockers T, Korte B, Wittkowski W, Winterhoff H (2002) Long-term effects of St. John\u2019s wort and hypericin on monoamine levels in rat hypothalamus and hippocampus. Brain Res 930:21\u201329", "ArticleIdList": ["11879791", "10.1016/S0006-8993(01)03394-7"]}, {"Citation": "Calapai G, Crupi A, Firenzuoli F, Costantino G, Inferrera G, Campo GM, Caputi AP (1999) Effects of Hypericum perforatum on levels of 5-hydroxytryptamine, noradrenaline and dopamine in the cortex, diencephalon and brainstem of the rat. J Pharm Pharmacol 51:723\u2013728", "ArticleIdList": ["10454050", "10.1211/0022357991772862"]}, {"Citation": "Calapai G, Crupi A, Firenzuoli F, Inferrera G, Squadrito F, Parisi A, De Sarro G, Caputi A (2001) Serotonin, norepinephrine and dopamine involvement in the antidepressant action of hypericum perforatum. Pharmacopsychiatry 34:45\u201349", "ArticleIdList": ["11302563", "10.1055/s-2001-15180"]}, {"Citation": "Chandley MJ, Szebeni A, Szebeni K, Crawford JD, Stockmeier CA, Turecki G, Kostrzewa RM, Ordway GA (2014) Elevated gene expression of glutamate receptors in noradrenergic neurons from the locus coeruleus in major depression. Int J Neuropsychopharmacol 17:1569\u20131578", "ArticleIdList": ["24925192", "10.1017/S1461145714000662"]}, {"Citation": "Chang Y, Wang SJ (2010) Hypericin, the active component of St. John\u2019s wort, inhibits glutamate release in the rat cerebrocortical synaptosomes via a mitogen-activated protein kinase-dependent pathway. Eur J Pharmacol 634:53\u201361", "ArticleIdList": ["20193678", "10.1016/j.ejphar.2010.02.035"]}, {"Citation": "Chatterjee SS, Bhattacharya SK, Wonnemann M, Singer A, Muller WE (1998) Hyperforin as a possible antidepressant component of hypericum extracts. Life Sci 63:499\u2013510", "ArticleIdList": ["9718074", "10.1016/S0024-3205(98)00299-9"]}, {"Citation": "Chen BK, Luna VM, Shannon ME, Hunsberger HC, Mastrodonato A, Stackmann M, McGowan JC, Rubinstenn G, Denny CA (2021) Fluoroethylnormemantine, a novel NMDA receptor antagonist, for the prevention and treatment of stress-induced maladaptive behavior. Biol Psychiatry 90:458\u2013472", "ArticleIdList": ["34274107", "10.1016/j.biopsych.2021.04.024"]}, {"Citation": "Clewell A, Barnes M, Endres JR, Ahmed M, Ghambeer DK (2012) Efficacy and tolerability assessment of a topical formulation containing copper sulfate and hypericum perforatum on patients with herpes skin lesions: a comparative, randomized controlled trial. J Drugs Dermatol 11:209\u2013215", "ArticleIdList": ["22270204"]}, {"Citation": "Cui YH, Zheng Y (2016) A meta-analysis on the efficacy and safety of St John\u2019s wort extract in depression therapy in comparison with selective serotonin reuptake inhibitors in adults. Neuropsychiatr Dis Treat 12:1715\u20131723", "ArticleIdList": ["27468236", "4946846", "10.2147/NDT.S106752"]}, {"Citation": "Dailly E, Chenu F, Renard CE, Bourin M (2004) Dopamine, depression and antidepressants. Fundam Clin Pharmacol 18:601\u2013607", "ArticleIdList": ["15548230", "10.1111/j.1472-8206.2004.00287.x"]}, {"Citation": "de Almeida GRL, Szczepanik JC, Selhorst I, Schmitz AE, Dos Santos B, Cunha MP, Heinrich IA, de Paula GC, De Bem AF, Leal RB, Dafre AL (2021) Methylglyoxal-mediated dopamine depletion, working memory deficit, and depression-like behavior are prevented by a dopamine/noradrenaline reuptake inhibitor. Mol Neurobiol 58:735\u2013749", "ArticleIdList": ["33011857", "10.1007/s12035-020-02146-3"]}, {"Citation": "Der-Avakian A, Markou A (2012) The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci 35:68\u201377", "ArticleIdList": ["22177980", "10.1016/j.tins.2011.11.005"]}, {"Citation": "Di Pierro F, Risso P, Settembre R (2018) Role in depression of a multi-fractionated versus a conventional Hypericum perforatum extract. Panminerva Med 60:156\u2013160", "ArticleIdList": ["29991209", "10.23736/S0031-0808.18.03518-8"]}, {"Citation": "Domany Y, Bleich-Cohen M, Tarrasch R, Meidan R, Litvak-Lazar O, Stoppleman N, Schreiber S, Bloch M, Hendler T, Sharon H (2019) Repeated oral ketamine for out-patient treatment of resistant depression: randomised, double-blind, placebo-controlled, proof-of-concept study. Br J Psychiatry 214:20\u201326", "ArticleIdList": ["30246667", "10.1192/bjp.2018.196"]}, {"Citation": "Duman RS, Voleti B (2012) Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents. Trends Neurosci 35:47\u201356", "ArticleIdList": ["22217452", "3278537", "10.1016/j.tins.2011.11.004"]}, {"Citation": "Eatemadnia A, Ansari S, Abedi P, Najar S (2019) The effect of Hypericum perforatum on postmenopausal symptoms and depression: a randomized controlled trial. Complement Ther Med 45:109\u2013113", "ArticleIdList": ["31331546", "10.1016/j.ctim.2019.05.028"]}, {"Citation": "El-Bakly WM, Hasanin AH (2014) Hypericum perforatum decreased hippocampus TNF-alpha and corticosterone levels with no effect on kynurenine/tryptophan ratio in bilateral ovariectomized rats. Korean J Physiol Pharmacol 18:233\u2013239", "ArticleIdList": ["24976763", "4071176", "10.4196/kjpp.2014.18.3.233"]}, {"Citation": "Eshaghi E, Sadigh-Eteghad S, Mohaddes G, Rasta SH (2019) Transcranial photobiomodulation prevents anxiety and depression via changing serotonin and nitric oxide levels in brain of depression model mice: a study of three different doses of 810 nm laser. Lasers Surg Med 51:634\u2013642", "ArticleIdList": ["30883832", "10.1002/lsm.23082"]}, {"Citation": "Estrada-Reyes R, Quero-Chavez DB, Trueta C, Miranda A, Valdes-Tovar M, Alarcon-Elizalde S, Oikawa-Sala J, Argueta J, Constantino-Jonapa LA, Munoz-Estrada J, Dubocovich ML, Benitez-King G (2021) Low doses of ketamine and melatonin in combination produce additive antidepressant-like effects in mice. Int J Mol Sci 22"}, {"Citation": "Fava M, Freeman MP, Flynn M, Judge H, Hoeppner BB, Cusin C, Ionescu DF, Mathew SJ, Chang LC, Iosifescu DV, Murrough J, Debattista C, Schatzberg AF, Trivedi MH, Jha MK, Sanacora G, Wilkinson ST, Papakostas GI (2020) Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD). Mol Psychiatry 25:1592\u20131603", "ArticleIdList": ["30283029", "10.1038/s41380-018-0256-5"]}, {"Citation": "Fegert JM, Kolch M, Zito JM, Glaeske G, Janhsen K (2006) Antidepressant use in children and adolescents in Germany. J Child Adolesc Psychopharmacol 16:197\u2013206", "ArticleIdList": ["16553540", "10.1089/cap.2006.16.197"]}, {"Citation": "Fernandes SS, Koth AP, Parfitt GM, Cordeiro MF, Peixoto CS, Soubhia A, Moreira FP, Wiener CD, Oses JP, Kaszubowski E, Barros DM (2018) Enhanced cholinergic-tone during the stress induce a depressive-like state in mice. Behav Brain Res 347:17\u201325", "ArticleIdList": ["29501509", "10.1016/j.bbr.2018.02.044"]}, {"Citation": "Ferrara M, Mungai F, Starace F (2017) St John\u2019s wort (Hypericum perforatum)-induced psychosis: a case report. J Med Case Rep 11:137", "ArticleIdList": ["28502251", "5430601", "10.1186/s13256-017-1302-7"]}, {"Citation": "Forbes EE, Hariri AR, Martin SL, Silk JS, Moyles DL, Fisher PM, Brown SM, Ryan ND, Birmaher B, Axelson DA, Dahl RE (2009) Altered striatal activation predicting real-world positive affect in adolescent major depressive disorder. Am J Psychiatry 166:64\u201373", "ArticleIdList": ["19047324", "10.1176/appi.ajp.2008.07081336"]}, {"Citation": "Franklin M, Cowen PJ (2001) Researching the antidepressant actions of Hypericum perforatum (St. John\u2019s wort) in animals and man. Pharmacopsychiatry 34 Suppl 1: S29\u201337"}, {"Citation": "Gall CM, Isackson PJ (1989) Limbic seizures increase neuronal production of messenger RNA for nerve growth factor. Science 245:758\u2013761", "ArticleIdList": ["2549634", "10.1126/science.2549634"]}, {"Citation": "Gambarana C, Ghiglieri O, Tolu P, De Montis MG, Giachetti D, Bombardelli E, Tagliamonte A (1999) Efficacy of an Hypericum perforatum (St. John\u2019s wort) extract in preventing and reverting a condition of escape deficit in rats. Neuropsychopharmacology 21:247\u2013257", "ArticleIdList": ["10432473", "10.1016/S0893-133X(99)00027-5"]}, {"Citation": "Gambarana C, Tolu PL, Masi F, Rinaldi M, Giachetti D, Morazzoni P, De Montis MG (2001) A study of the antidepressant activity of Hypericum perforatum on animal models. Pharmacopsychiatry 34(Suppl 1):S42-44", "ArticleIdList": ["11518074", "10.1055/s-2001-15515"]}, {"Citation": "Gandelman JA, Newhouse P, Taylor WD (2018) Nicotine and networks: potential for enhancement of mood and cognition in late-life depression. Neurosci Biobehav Rev 84:289\u2013298", "ArticleIdList": ["28859996", "10.1016/j.neubiorev.2017.08.018"]}, {"Citation": "Ghazanfarpour M, Kaviani M, Asadi N, Ghaffarpasand F, Ziyadlou S, Tabatabaee HR, Dehghankhalili M (2011) Hypericum perforatum for the treatment of premenstrual syndrome. Int J Gynaecol Obstet 113:84\u201385", "ArticleIdList": ["21315349", "10.1016/j.ijgo.2010.11.007"]}, {"Citation": "Goldberg JS, Bell CE Jr, Pollard DA (2014) Revisiting the monoamine hypothesis of depression: a new perspective. Perspect Medicin Chem 6:1\u20138", "ArticleIdList": ["24737931", "3981571", "10.4137/PMC.S11375"]}, {"Citation": "Hajhashemi M, Ghanbari Z, Movahedi M, Rafieian M, Keivani A, Haghollahi F (2018) The effect of Achillea millefolium and Hypericum perforatum ointments on episiotomy wound healing in primiparous women. J Matern Fetal Neonatal Med 31:63\u201369", "ArticleIdList": ["28027682", "10.1080/14767058.2016.1275549"]}, {"Citation": "Hamon M, Blier P (2013) Monoamine neurocircuitry in depression and strategies for new treatments. Prog Neuropsychopharmacol Biol Psychiatry 45:54\u201363", "ArticleIdList": ["23602950", "10.1016/j.pnpbp.2013.04.009"]}, {"Citation": "Hanada Y, Kawahara Y, Ohnishi YN, Shuto T, Kuroiwa M, Sotogaku N, Greengard P, Sagi Y, Nishi A (2018) p11 in cholinergic interneurons of the nucleus accumbens is essential for dopamine responses to rewarding stimuli. eNeuro 5"}, {"Citation": "Hasler G, Fromm S, Carlson PJ, Luckenbaugh DA, Waldeck T, Geraci M, Roiser JP, Neumeister A, Meyers N, Charney DS, Drevets WC (2008) Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects. Arch Gen Psychiatry 65:521\u2013531", "ArticleIdList": ["18458204", "2676777", "10.1001/archpsyc.65.5.521"]}, {"Citation": "Higley MJ, Picciotto MR (2014) Neuromodulation by acetylcholine: examples from schizophrenia and depression. Curr Opin Neurobiol 29:88\u201395", "ArticleIdList": ["24983212", "10.1016/j.conb.2014.06.004"]}, {"Citation": "Husain GM, Chatterjee SS, Singh PN, Kumar V (2011) Beneficial effect of Hypericum perforatum on depression and anxiety in a type 2 diabetic rat model. Acta Pol Pharm 68:913\u2013918", "ArticleIdList": ["22125957"]}, {"Citation": "Jang CG, Kang M, Cho JH, Lee SB, Kim H, Park S, Lee J, Park SK, Hong M, Shin MK, Shim IS, Bae H (2004) Nelumbinis Semen reverses a decrease in 5-HT1A receptor binding induced by chronic mild stress, a depression-like symptom. Arch Pharm Res 27:1065\u20131072", "ArticleIdList": ["15554266", "10.1007/BF02975433"]}, {"Citation": "Jaworek AK, Jaworek M, Makara-Studzinska M, Szafraniec K, Doniec Z, Szepietowski J, Wojas-Pelc A, Pokorski M (2020) Depression and serum content of serotonin in adult patients with atopic dermatitis. Adv Exp Med Biol 1271:83\u201388", "ArticleIdList": ["31916233", "10.1007/5584_2019_470"]}, {"Citation": "Johne A, Schmider J, Brockmoller J, Stadelmann AM, Stormer E, Bauer S, Scholler G, Langheinrich M, Roots I (2002) Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St. John\u2019s wort (Hypericum perforatum). J Clin Psychopharmacol 22:46\u201354", "ArticleIdList": ["11799342", "10.1097/00004714-200202000-00008"]}, {"Citation": "Kaehler ST, Sinner C, Chatterjee SS, Philippu A (1999) Hyperforin enhances the extracellular concentrations of catecholamines, serotonin and glutamate in the rat locus coeruleus. Neurosci Lett 262:199\u2013202", "ArticleIdList": ["10218890", "10.1016/S0304-3940(99)00087-7"]}, {"Citation": "Kalb R, Trautmann-Sponsel RD, Kieser M (2001) Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial. Pharmacopsychiatry 34:96\u2013103", "ArticleIdList": ["11434406", "10.1055/s-2001-14280"]}, {"Citation": "Kandilarov IK, Zlatanova HI, Georgieva-Kotetarova MT, Kostadinova II, Katsarova MN, Dimitrova SZ, Lukanov LK, Sadakov F (2018) Antidepressant effect and recognition memory improvement of two novel plant extract combinations - antistress I and anti-stress II on rats subjected to a model of mild chronic stress. Folia Med (plovdiv) 60:110\u2013116", "ArticleIdList": ["10.1515/folmed-2017-0073"]}, {"Citation": "Kanekar S, Ettaro R, Hoffman MD, Ombach HJ, Brown J, Lynch C, Sheth CS, Renshaw PF (2021) Sex-based impact of creatine supplementation on depressive symptoms, brain serotonin and SSRI efficacy in an animal model of treatment-resistant depression. Int J Mol Sci 22"}, {"Citation": "Kang M, Shin D, Oh JW, Cho C, Lee HJ, Yoon DW, Lee SM, Yun JH, Choi H, Park S, Shin M, Hong M, Bae H (2005) The anti-depressant effect of Nelumbinis semen on rats under chronic mild stress induced depression-like symptoms. Am J Chin Med 33:205\u2013213", "ArticleIdList": ["15974480", "10.1142/S0192415X05002874"]}, {"Citation": "Karolewicz B, Szebeni K, Gilmore T, Maciag D, Stockmeier CA, Ordway GA (2009) Elevated levels of NR2A and PSD-95 in the lateral amygdala in depression. Int J Neuropsychopharmacol 12:143\u2013153", "ArticleIdList": ["18570704", "10.1017/S1461145708008985"]}, {"Citation": "Kasper S, Anghelescu IG, Szegedi A, Dienel A, Kieser M (2006) Superior efficacy of St John\u2019s wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298]. BMC Med 4:14", "ArticleIdList": ["16796730", "1538611", "10.1186/1741-7015-4-14"]}, {"Citation": "Kasper S, Anghelescu IG, Szegedi A, Dienel A, Kieser M (2007) Placebo controlled continuation treatment with Hypericum extract WS 5570 after recovery from a mild or moderate depressive episode. Wien Med Wochenschr 157:362\u2013366", "ArticleIdList": ["17704988", "10.1007/s10354-007-0441-7"]}, {"Citation": "Kasper S, Gastpar M, Moller HJ, Muller WE, Volz HP, Dienel A, Kieser M (2010) Better tolerability of St. John\u2019s wort extract WS 5570 compared to treatment with SSRIs: a reanalysis of data from controlled clinical trials in acute major depression. Int Clin Psychopharmacol 25:204\u2013213", "ArticleIdList": ["20568656", "10.1097/YIC.0b013e328335dc1a"]}, {"Citation": "Kendell SF, Krystal JH, Sanacora G (2005) GABA and glutamate systems as therapeutic targets in depression and mood disorders. Expert Opin Ther Targets 9:153\u2013168", "ArticleIdList": ["15757488", "10.1517/14728222.9.1.153"]}, {"Citation": "Kiewert C, Buchholzer ML, Hartmann J, Chatterjee SS, Klein J (2004) Stimulation of hippocampal acetylcholine release by hyperforin, a constituent of St. John\u2019s Wort Neurosci Lett 364:195\u2013198", "ArticleIdList": ["15196674", "10.1016/j.neulet.2004.04.046"]}, {"Citation": "Kram ML, Kramer GL, Ronan PJ, Steciuk M, Petty F (2002) Dopamine receptors and learned helplessness in the rat: an autoradiographic study. Prog Neuropsychopharmacol Biol Psychiatry 26:639\u2013645", "ArticleIdList": ["12188094", "10.1016/S0278-5846(01)00222-6"]}, {"Citation": "Kulkarni SK, Akula KK, Deshpande J (2012) Evaluation of antidepressant-like activity of novel water-soluble curcumin formulations and St. John\u2019s wort in behavioral paradigms of despair. Pharmacology 89:83\u201390", "ArticleIdList": ["22343362", "10.1159/000335660"]}, {"Citation": "Kumar V, Singh PN, Jaiswal AK, Bhattacharya SK (1999) Antidepressant activity of Indian Hypericum perforatum Linn in rodents. Indian J Exp Biol 37:1171\u20131176", "ArticleIdList": ["10865882"]}, {"Citation": "Lauterborn JC, Lynch G, Vanderklish P, Arai A, Gall CM (2000) Positive modulation of AMPA receptors increases neurotrophin expression by hippocampal and cortical neurons. J Neurosci 20:8\u201321", "ArticleIdList": ["10627576", "6774091", "10.1523/JNEUROSCI.20-01-00008.2000"]}, {"Citation": "Lee B, Choi GM, Sur B (2020) Silibinin prevents depression-like behaviors in a single prolonged stress rat model: the possible role of serotonin. BMC Complement Med Ther 20:70", "ArticleIdList": ["32143600", "7076861", "10.1186/s12906-020-2868-y"]}, {"Citation": "Lei HP, Yu XY, Xie HT, Li HH, Fan L, Dai LL, Chen Y, Zhou HH (2010) Effect of St. John\u2019s wort supplementation on the pharmacokinetics of bupropion in healthy male Chinese volunteers. Xenobiotica 40:275\u2013281", "ArticleIdList": ["20102294", "10.3109/00498250903509383"]}, {"Citation": "Li X, Tizzano JP, Griffey K, Clay M, Lindstrom T, Skolnick P (2001) Antidepressant-like actions of an AMPA receptor potentiator (LY392098). Neuropharmacology 40:1028\u20131033", "ArticleIdList": ["11406194", "10.1016/S0028-3908(00)00194-5"]}, {"Citation": "Li J, Sha L, Xu Q (2020) An early increase in glutamate is critical for the development of depression-like behavior in a chronic restraint stress (CRS) model. Brain Res Bull 162:59\u201366", "ArticleIdList": ["32505508", "10.1016/j.brainresbull.2020.05.013"]}, {"Citation": "Liu C, Hao S, Zhu M, Wang Y, Zhang T, Yang Z (2018) Maternal separation induces different autophagic responses in the hippocampus and prefrontal cortex of adult rats. Neuroscience 374:287\u2013294", "ArticleIdList": ["29391188", "10.1016/j.neuroscience.2018.01.043"]}, {"Citation": "Lu X, Ce Q, Jin L, Zheng J, Sun M, Tang X, Li D, Sun J (2021) Deoiled sunflower seeds ameliorate depression by promoting the production of monoamine neurotransmitters and inhibiting oxidative stress. Food Funct 12:573\u2013586", "ArticleIdList": ["33367360", "10.1039/D0FO01978J"]}, {"Citation": "Ma J, Huang Z, Wang S, Zheng S, Duan K (2019) Postpartum depression: association with genetic polymorphisms of noradrenaline metabolic enzymes and the risk factors. Nan Fang Yi Ke Da Xue Xue Bao 39:57\u201362", "ArticleIdList": ["30692067"]}, {"Citation": "Madeira C, Vargas-Lopes C, Brandao CO, Reis T, Laks J, Panizzutti R, Ferreira ST (2018) Elevated glutamate and glutamine levels in the cerebrospinal fluid of patients with probable Alzheimer\u2019s disease and depression. Front Psychiatry 9:561", "ArticleIdList": ["30459657", "6232456", "10.3389/fpsyt.2018.00561"]}, {"Citation": "Masuoka T, Tateno A, Sakayori T, Tiger M, Kim W, Moriya H, Ueda S, Arakawa R, Okubo Y (2020) Electroconvulsive therapy decreases striatal dopamine transporter binding in patients with depression: a positron emission tomography study with [(18)F]FE-PE2I. Psychiatry Res Neuroimaging 301: 111086"}, {"Citation": "Mayo GM, Langridge P (2003) Modes of reproduction in Australian populations of Hypericum perforatum L. (St. John\u2019s wort) revealed by DNA fingerprinting and cytological methods. Genome 46:573\u2013579", "ArticleIdList": ["12897865", "10.1139/g03-038"]}, {"Citation": "McEwen BS (1999) Stress and hippocampal plasticity. Annu Rev Neurosci 22:105\u2013122", "ArticleIdList": ["10202533", "10.1146/annurev.neuro.22.1.105"]}, {"Citation": "McFadden SL, Hooker BL (2020) Comparing perika St. John\u2019s wort and sertraline for treatment of posttraumatic stress disorder in mice. J Diet Suppl 17:300\u2013308", "ArticleIdList": ["30773961", "10.1080/19390211.2019.1572040"]}, {"Citation": "Melzer J, Brignoli R, Keck ME, Saller R (2010) A hypericum extract in the treatment of depressive symptoms in outpatients: an open study. Forsch Komplementmed 17:7\u201314", "ArticleIdList": ["20215757", "10.1159/000277628"]}, {"Citation": "Menegazzi M, Masiello P, Novelli M (2020) Anti-tumor activity of Hypericum perforatum L. and Hyperforin through modulation of inflammatory signaling, ROS generation and proton dynamics. Antioxidants (Basel) 10"}, {"Citation": "Minami S, Satoyoshi H, Ide S, Inoue T, Yoshioka M, Minami M (2017) Suppression of reward-induced dopamine release in the nucleus accumbens in animal models of depression: differential responses to drug treatment. Neurosci Lett 650:72\u201376", "ArticleIdList": ["28432029", "10.1016/j.neulet.2017.04.028"]}, {"Citation": "Moriguchi S, Takamiya A, Noda Y, Horita N, Wada M, Tsugawa S, Plitman E, Sano Y, Tarumi R, ElSalhy M, Katayama N, Ogyu K, Miyazaki T, Kishimoto T, Graff-Guerrero A, Meyer JH, Blumberger DM, Daskalakis ZJ, Mimura M, Nakajima S (2019) Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies. Mol Psychiatry 24:952\u2013964", "ArticleIdList": ["30315224", "10.1038/s41380-018-0252-9"]}, {"Citation": "Muller WE, Rolli M, Schafer C, Hafner U (1997) Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity. Pharmacopsychiatry 30(Suppl 2):102\u2013107", "ArticleIdList": ["9342769", "10.1055/s-2007-979528"]}, {"Citation": "Muller WE, Singer A, Wonnemann M, Hafner U, Rolli M, Schafer C (1998) Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract. Pharmacopsychiatry 31(Suppl 1):16\u201321", "ArticleIdList": ["9684943", "10.1055/s-2007-979341"]}, {"Citation": "Muller WE, Singer A, Wonnemann M (2000) [Mechanism of action of St. Johns wort extract]. Praxis (Bern 1994) 89: 2111\u20132121"}, {"Citation": "M\u00fcller WE (2005) St. John\u2019s wort and its active principles in depression and anxiety. Springer Science & Business Media"}, {"Citation": "Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Green CE, Perez AM, Iqbal S, Pillemer S, Foulkes A, Shah A, Charney DS, Mathew SJ (2013) Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry 170:1134\u20131142", "ArticleIdList": ["23982301", "3992936", "10.1176/appi.ajp.2013.13030392"]}, {"Citation": "Nathan P (1999) The experimental and clinical pharmacology of St John\u2019s wort (Hypericum perforatum L.). Mol Psychiatry 4:333\u2013338", "ArticleIdList": ["10483049", "10.1038/sj.mp.4000557"]}, {"Citation": "Navarria A, Wohleb ES, Voleti B, Ota KT, Dutheil S, Lepack AE, Dwyer JM, Fuchikami M, Becker A, Drago F, Duman RS (2015) Rapid antidepressant actions of scopolamine: role of medial prefrontal cortex and M1-subtype muscarinic acetylcholine receptors. Neurobiol Dis 82:254\u2013261", "ArticleIdList": ["26102021", "4640941", "10.1016/j.nbd.2015.06.012"]}, {"Citation": "Ng QX, Venkatanarayanan N, Ho CY (2017) Clinical use of Hypericum perforatum (St John\u2019s wort) in depression: a meta-analysis. J Affect Disord 210:211\u2013221", "ArticleIdList": ["28064110", "10.1016/j.jad.2016.12.048"]}, {"Citation": "Niederhofer H (2010) St. John\u2019s wort may improve some symptoms of attention-deficit hyperactivity disorder. Nat Prod Res 24:203\u2013205", "ArticleIdList": ["20140799", "10.1080/14786410802076259"]}, {"Citation": "Nosyreva E, Szabla K, Autry AE, Ryazanov AG, Monteggia LM, Kavalali ET (2013) Acute suppression of spontaneous neurotransmission drives synaptic potentiation. J Neurosci 33:6990\u20137002", "ArticleIdList": ["23595756", "3661220", "10.1523/JNEUROSCI.4998-12.2013"]}, {"Citation": "Nowak G, Ordway GA, Paul IA (1995) Alterations in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims. Brain Res 675:157\u2013164", "ArticleIdList": ["7796124", "10.1016/0006-8993(95)00057-W"]}, {"Citation": "Onaolapo AY, Onaolapo OJ (2021) Glutamate and depression: reflecting a deepening knowledge of the gut and brain effects of a ubiquitous molecule. World J Psychiatry 11:297\u2013315", "ArticleIdList": ["34327123", "8311508", "10.5498/wjp.v11.i7.297"]}, {"Citation": "O\u2019Sullivan JB, Ryan KM, Curtin NM, Harkin A, Connor TJ (2009) Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration. Int J Neuropsychopharmacol 12:687\u2013699", "ArticleIdList": ["19046481", "10.1017/S146114570800967X"]}, {"Citation": "Pereira JC Jr, Pradella-Hallinan M, Alves RC (2013) Saint John\u2019s wort, an herbal inducer of the cytochrome P4503A4 isoform, may alleviate symptoms of Willis-Ekbom\u2019s disease. Clinics (sao Paulo) 68:469\u2013474", "ArticleIdList": ["10.6061/clinics/2013(04)06"]}, {"Citation": "Philippu A (2001) In vivo neurotransmitter release in the locus coeruleus\u2014effects of hyperforin, inescapable shock and fear. Pharmacopsychiatry 34(Suppl 1):S111-115", "ArticleIdList": ["11518058", "10.1055/s-2001-15448"]}, {"Citation": "Pochwat B, Szewczyk B, Kotarska K, Rafalo-Ulinska A, Siwiec M, Sowa JE, Tokarski K, Siwek A, Bouron A, Friedland K, Nowak G (2018) Hyperforin potentiates antidepressant-like activity of lanicemine in mice. Front Mol Neurosci 11:456", "ArticleIdList": ["30618608", "6299069", "10.3389/fnmol.2018.00456"]}, {"Citation": "Popova V, Daly EJ, Trivedi M, Cooper K, Lane R, Lim P, Mazzucco C, Hough D, Thase ME, Shelton RC, Molero P, Vieta E, Bajbouj M, Manji H, Drevets WC, Singh JB (2019) Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized double-blind active-controlled study. Am J Psychiatry 176:428\u2013438", "ArticleIdList": ["31109201", "10.1176/appi.ajp.2019.19020172"]}, {"Citation": "Powers B, Joyce C, Kleinman JE, Hyde TM, Ajilore O, Leow A, Sodhi MS (2020) Sex differences in the transcription of glutamate transporters in major depression and suicide. J Affect Disord 277:244\u2013252", "ArticleIdList": ["32836031", "10.1016/j.jad.2020.07.055"]}, {"Citation": "Rabasseda X (2004) Duloxetine: a new serotonin/noradrenaline reuptake inhibitor for the treatment of depression. Drugs Today (barc) 40:773\u2013790", "ArticleIdList": ["10.1358/dot.2004.40.9.850497"]}, {"Citation": "Rappeneau V, Blaker A, Petro JR, Yamamoto BK, Shimamoto A (2016) Disruption of the glutamate-glutamine cycle involving astrocytes in an animal model of depression for males and females. Front Behav Neurosci 10:231", "ArticleIdList": ["28018190", "5147055", "10.3389/fnbeh.2016.00231"]}, {"Citation": "Re L, Corneli C, Sturani E, Paolucci G, Rossini F, Leon OS, Martinez G, Bordicchia M, Tomassetti Q (2003) Effects of Hypericum extract on the acetylcholine release: a loose patch clamp approach. Pharmacol Res 48:55\u201360", "ArticleIdList": ["12770515"]}, {"Citation": "Reddy PL, Khanna S, Subhash MN, Channabasavanna SM, Rao BS (1992) CSF amine metabolites in depression. Biol Psychiatry 31:112\u2013118", "ArticleIdList": ["1371076", "10.1016/0006-3223(92)90198-9"]}, {"Citation": "Ruedeberg C, Wiesmann UN, Brattstroem A, Honegger UE (2010) Hypericum perforatum L. (St John\u2019s wort) extract Ze 117 inhibits dopamine re-uptake in rat striatal brain slices. An implication for use in smoking cessation treatment? Phytother Res 24:249\u2013251", "ArticleIdList": ["19585471", "10.1002/ptr.2921"]}, {"Citation": "Sahraei M, Sahraei H, Rahimi M, Khosravi M, Ganjkhani M, Meftahi GH (2021) Anxiogenic and anxiolytic effects of memantine injected into the ventral hippocampus in male stressed mice. J Complement Integr Med"}, {"Citation": "Salamone JD, Correa M, Mingote S, Weber SM (2003) Nucleus accumbens dopamine and the regulation of effort in food-seeking behavior: implications for studies of natural motivation, psychiatry, and drug abuse. J Pharmacol Exp Ther 305:1\u20138", "ArticleIdList": ["12649346", "10.1124/jpet.102.035063"]}, {"Citation": "Sanacora G, Gueorguieva R, Epperson CN, Wu YT, Appel M, Rothman DL, Krystal JH, Mason GF (2004) Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry 61:705\u2013713", "ArticleIdList": ["15237082", "10.1001/archpsyc.61.7.705"]}, {"Citation": "Sarchiapone M, Carli V, Camardese G, Cuomo C, Di Giuda D, Calcagni ML, Focacci C, De Risio S (2006) Dopamine transporter binding in depressed patients with anhedonia. Psychiatry Res 147:243\u2013248", "ArticleIdList": ["16952448", "10.1016/j.pscychresns.2006.03.001"]}, {"Citation": "Seno S, Tomura S, Miyazaki H, Sato S, Saitoh D (2021) Effects of selective serotonin reuptake inhibitors on depression-like behavior in a laser-induced shock wave model. Front Neurol 12: 602038"}, {"Citation": "Sevastre-Berghian AC, Toma VA, Sevastre B, Hanganu D, Vlase L, Benedec D, Oniga I, Baldea I, Olteanu D, Moldovan R, Decea N, Filip GA, Clichici SV (2018) Characterization and biological effects of Hypericum extracts on experimentally-induced - anxiety, oxidative stress and inflammation in rats. J Physiol Pharmacol 69"}, {"Citation": "Singer A, Wonnemann M, Muller WE (1999) Hyperforin, a major antidepressant constituent of St. John\u2019s wort, inhibits serotonin uptake by elevating free intracellular Na+1. J Pharmacol Exp Ther 290:1363\u20131368", "ArticleIdList": ["10454515"]}, {"Citation": "Singer A, Schmidt M, Hauke W, Stade K (2011) Duration of response after treatment of mild to moderate depression with Hypericum extract STW 3-VI, citalopram and placebo: a reanalysis of data from a controlled clinical trial. Phytomedicine 18:739\u2013742", "ArticleIdList": ["21514125", "10.1016/j.phymed.2011.02.016"]}, {"Citation": "Soga T, Teo CH, Parhar I (2020) Genetic and epigenetic consequence of early-life social stress on depression: role of serotonin-associated genes. Front Genet 11: 601868"}, {"Citation": "Soleymani S, Bahramsoltani R, Rahimi R, Abdollahi M (2017) Clinical risks of St John\u2019s wort (Hypericum perforatum) co-administration. Expert Opin Drug Metab Toxicol 13:1047\u20131062", "ArticleIdList": ["28885074", "10.1080/17425255.2017.1378342"]}, {"Citation": "Solomon D, Adams J, Graves N (2013) Economic evaluation of St. John\u2019s wort (Hypericum perforatum) for the treatment of mild to moderate depression. J Affect Disord 148:228\u2013234", "ArticleIdList": ["23291009", "10.1016/j.jad.2012.11.064"]}, {"Citation": "Stage TB, Pedersen RS, Damkier P, Christensen MM, Feddersen S, Larsen JT, Hojlund K, Brosen K (2015) Intake of St John\u2019s wort improves the glucose tolerance in healthy subjects who ingest metformin compared with metformin alone. Br J Clin Pharmacol 79:298\u2013306", "ArticleIdList": ["25223504", "4309635", "10.1111/bcp.12510"]}, {"Citation": "Szewczyk B, Pochwat B, Muszynska B, Opoka W, Krakowska A, Rafalo-Ulinska A, Friedland K, Nowak G (2019) Antidepressant-like activity of hyperforin and changes in BDNF and zinc levels in mice exposed to chronic unpredictable mild stress. Behav Brain Res 372: 112045"}, {"Citation": "Taylor LH, Kobak KA (2000) An open-label trial of St. John\u2019s wort (Hypericum perforatum) in obsessive-compulsive disorder. J Clin Psychiatry 61:575\u2013578", "ArticleIdList": ["10982200", "10.4088/JCP.v61n0806"]}, {"Citation": "Tian J, Zhang F, Cheng J, Guo S, Liu P, Wang H (2014) Antidepressant-like activity of adhyperforin, a novel constituent of Hypericum perforatum L. Sci Rep 4:5632", "ArticleIdList": ["25005489", "4088061", "10.1038/srep05632"]}, {"Citation": "Tingle JL, Cook-Patton SC, Agrawal AA (2016) Spillover of a biological control agent (Chrysolina quadrigemina) onto native St. Johnswort (Hypericum punctatum). PeerJ 4: e1886"}, {"Citation": "Tokgoz HB, Altan F (2020) Hypericum perforatum L.: a medicinal plant with potential as a curative agent against obesity-associated complications. Mol Biol Rep 47:8679\u20138686", "ArticleIdList": ["33090307", "10.1007/s11033-020-05912-7"]}, {"Citation": "Trofimiuk E, Walesiuk A, Braszko JJ (2005) St John\u2019s wort (Hypericum perforatum) diminishes cognitive impairment caused by the chronic restraint stress in rats. Pharmacol Res 51:239\u2013246", "ArticleIdList": ["15661574", "10.1016/j.phrs.2004.08.007"]}, {"Citation": "Tu P, Gibon J, Bouron A (2010) The TRPC6 channel activator hyperforin induces the release of zinc and calcium from mitochondria. J Neurochem 112:204\u2013213", "ArticleIdList": ["19845832", "10.1111/j.1471-4159.2009.06446.x"]}, {"Citation": "Urichuk L, Prior TI, Dursun S, Baker G (2008) Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactions. Curr Drug Metab 9:410\u2013418", "ArticleIdList": ["18537577", "10.2174/138920008784746373"]}, {"Citation": "Usai M, Leggio B, Grappi S, Nanni G, Gambarana C, Tolu P, Giachetti D, De Montis MG (2003) Hypericum perforatum subspecies angustifolium shows a protective activity on the consequences of unavoidable stress exposure at lower doses than Hypericum perforatum perforatum. Pharmacopsychiatry 36:283\u2013287", "ArticleIdList": ["14663651", "10.1055/s-2003-45114"]}, {"Citation": "Van Strater AC, Bogers JP (2012) Interaction of St John\u2019s wort (Hypericum perforatum) with clozapine. Int Clin Psychopharmacol 27:121\u2013124", "ArticleIdList": ["22113252", "10.1097/YIC.0b013e32834e8afd"]}, {"Citation": "Vance KM, Ribnicky DM, Hermann GE, Rogers RC (2014) St. John\u2019s wort enhances the synaptic activity of the nucleus of the solitary tract. Nutrition 30:S37-42", "ArticleIdList": ["24985104", "4128486", "10.1016/j.nut.2014.02.008"]}, {"Citation": "Wang P, Gao X, Zhao F, Gao Y, Wang K, Tian JS, Li Z, Qin XM (2021a) Study of the neurotransmitter changes adjusted by circadian rhythm in depression based on liver transcriptomics and correlation analysis. ACS Chem Neurosci 12:2151\u20132166", "ArticleIdList": ["34060807", "10.1021/acschemneuro.1c00115"]}, {"Citation": "Wang S, Leri F, Rizvi SJ (2021b) Anhedonia as a central factor in depression: neural mechanisms revealed from preclinical to clinical evidence. Prog Neuropsychopharmacol Biol Psychiatry 110: 110289"}, {"Citation": "Wang S, Wang S, Wang Y, Xin Y, Zhang J, Yang Z, Liu C (2021c) Hyperforin alleviates the psychiatric disorders of adult rats suffered from early maternal separation via activating autophagy. Neurosci Lett 750: 135750"}, {"Citation": "Warnick SJ Jr, Mehdi L, Kowalkowski J (2021) Wait\u2014there\u2019s evidence for that? Integrative medicine treatments for major depressive disorder. Int J Psychiatry Med 56:334\u2013343", "ArticleIdList": ["34521233", "10.1177/00912174211046353"]}, {"Citation": "Warren MB, Cowen PJ, Harmer CJ (2019) Subchronic treatment with St John\u2019s wort produces a positive shift in emotional processing in healthy volunteers. J Psychopharmacol 33:194\u2013201", "ArticleIdList": ["30484733", "10.1177/0269881118812101"]}, {"Citation": "Whiteside GT, Dwyer JM, Harrison JE, Beyer CE, Cummons T, Manzino L, Mark L, Johnston GH, Strassle BW, Adedoyin A, Lu P, Piesla MJ, Pulicicchio CM, Erve JC, Platt BJ, Hughes ZA, Rogers KE, Deecher DC, Trybulski EJ, Kennedy JD, Zhang P, Leventhal L (2010) WAY-318068: a novel, potent and selective noradrenaline re-uptake inhibitor with activity in rodent models of pain and depression. Br J Pharmacol 160:1105\u20131118", "ArticleIdList": ["20590604", "2936020", "10.1111/j.1476-5381.2010.00690.x"]}, {"Citation": "Wonnemann M, Singer A, Muller WE (2000) Inhibition of synaptosomal uptake of 3H-L-glutamate and 3H-GABA by hyperforin, a major constituent of St. John\u2019s Wort: the role of amiloride sensitive sodium conductive pathways. Neuropsychopharmacology 23:188\u2013197", "ArticleIdList": ["10882845", "10.1016/S0893-133X(00)00102-0"]}, {"Citation": "Xu X, Wei Y, Guo Q, Zhao S, Liu Z, Xiao T, Liu Y, Qiu Y, Hou Y, Zhang G, Wang K (2018) Pharmacological characterization of H05, a novel serotonin and noradrenaline reuptake inhibitor with moderate 5-HT2A antagonist activity for the treatment of depression. J Pharmacol Exp Ther 365:624\u2013635", "ArticleIdList": ["29615471", "10.1124/jpet.118.248351"]}, {"Citation": "Yadid G, Friedman A (2008) Dynamics of the dopaminergic system as a key component to the understanding of depression. Prog Brain Res 172:265\u2013286", "ArticleIdList": ["18772037", "10.1016/S0079-6123(08)00913-8"]}, {"Citation": "Yoshitake T, Iizuka R, Yoshitake S, Weikop P, Muller WE, Ogren SO, Kehr J (2004) Hypericum perforatum L (St John\u2019s wort) preferentially increases extracellular dopamine levels in the rat prefrontal cortex. Br J Pharmacol 142:414\u2013418", "ArticleIdList": ["15148244", "1574978", "10.1038/sj.bjp.0705822"]}, {"Citation": "Yu B, Sun Y, Lu GH, Lu JF, Fang TH (2011) Influence of electroacupuncture plus intragastric administration of extract of hypericum perforatum L on ethology and brain microcirculation in depression rats. Zhen Ci Yan Jiu 36:164\u2013170", "ArticleIdList": ["21793379"]}, {"Citation": "Zafra F, Castren E, Thoenen H, Lindholm D (1991) Interplay between glutamate and gamma-aminobutyric acid transmitter systems in the physiological regulation of brain-derived neurotrophic factor and nerve growth factor synthesis in hippocampal neurons. Proc Natl Acad Sci U S A 88:10037\u201310041", "ArticleIdList": ["1658793", "52862", "10.1073/pnas.88.22.10037"]}, {"Citation": "Zanos P, Gould TD (2018) Mechanisms of ketamine action as an antidepressant. Mol Psychiatry 23:801\u2013811", "ArticleIdList": ["29532791", "5999402", "10.1038/mp.2017.255"]}, {"Citation": "Zobayed SM, Afreen F, Goto E, Kozai T (2006) Plant-environment interactions: Accumulation of hypericin in dark glands of Hypericum perforatum. Ann Bot 98:793\u2013804", "ArticleIdList": ["16891333", "2806163", "10.1093/aob/mcl169"]}], "ReferenceList": [], "Title": "References"}], "History": [{"Year": "2021", "Month": "11", "Day": "26"}, {"Year": "2022", "Month": "3", "Day": "10"}, {"Year": "2022", "Month": "3", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "5", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "16", "Hour": "17", "Minute": "16"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35294606", "10.1007/s00210-022-02229-z", "10.1007/s00210-022-02229-z"]}}], "PubmedBookArticle": []}